Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Dec 15;61 Suppl 8(Suppl 8):S837-48.
doi: 10.1093/cid/civ738.

A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections

Elissa Meites  1 , Charlotte A Gaydos  2 , Marcia M Hobbs  3 , Patricia Kissinger  4 , Paul Nyirjesy  5 , Jane R Schwebke  6 , W Evan Secor  7 , Jack D Sobel  8 , Kimberly A Workowski  9
Affiliations
Review

A Review of Evidence-Based Care of Symptomatic Trichomoniasis and Asymptomatic Trichomonas vaginalis Infections

Elissa Meites et al. Clin Infect Dis. .

Abstract

Trichomonas vaginalis is the most prevalent nonviral sexually transmitted infection, affecting an estimated 3.7 million women and men in the United States. Health disparities are prominent in the epidemiology of this infection, which affects 11% of women aged ≥40 years and a disproportionately high percentage of black women. Particularly high prevalences have been identified among sexually transmitted disease (STD) clinic patients and incarcerated individuals. This article reviews and updates scientific evidence in key topic areas used for the development of the 2015 STD Treatment Guidelines published by the Centers for Disease Control and Prevention. Current evidence is presented regarding conditions associated with Trichomonas vaginalis infection, including human immunodeficiency virus (HIV) and pregnancy complications such as preterm birth. Nucleic acid amplification tests and point-of-care tests are newly available diagnostic methods that can be conducted on a variety of specimens, potentially allowing highly sensitive testing and screening of both women and men at risk for infection. Usually, trichomoniasis can be cured with single-dose therapy of an appropriate nitroimidazole antibiotic, but women who are also infected with HIV should receive therapy for 7 days. Antimicrobial resistance is an emerging concern.

Keywords: Trichomonas infections; Trichomonas vaginalis; Trichomonas vaginitis; antitrichomonal agents; sexually transmitted diseases.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bachmann LH, Hobbs MM, Seña AC et al. . Trichomonas vaginalis genital infections: progress and challenges. Clin Infect Dis 2011; 53(suppl 3):S160–72. - PMC - PubMed
    1. Satterwhite CL, Torrone E, Meites E et al. . Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis 2013; 40:187–93. - PubMed
    1. Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis 2007; 45:1319–26. - PubMed
    1. Miller WC, Swygard H, Hobbs MM et al. . The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis 2005; 32:593–8. - PubMed
    1. Mullins TL, Rudy BJ, Wilson CM, Sucharew H, Kahn JA. Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA. Int J STD AIDS 2013; 24:123–7. - PMC - PubMed

MeSH terms

Substances